Navigating Japan’s Unique Oncology Real-World Data Landscape

The webinar features a panel of specialists, including Eri Tajima of Flatiron Health, Dr. Hideaki Bando and Dr. Yasushi Goto from the National Cancer Center Hospital East and National Cancer Center Hospital, alongside GSK’s Dina Oksen. The discussion centers on the divergence between Japanese data sources and those typically utilized in the US and Europe. A primary focus will be the integration of electronic health record-derived data, which differs significantly from standard claims or registry-based datasets.

Global biopharma teams often struggle with the nuances of local care delivery models and the specific quality requirements for evidence planning in Japan. Participants will examine how to bridge these gaps, emphasizing the practicalities of partnering with local experts. The session aims to provide a framework for sponsors seeking to incorporate Japanese insights into a broader, representative global research strategy.